ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Age (years): 62 12 Male %: 78 Family origin not reported Setting: Multicentre Country: USA and Canada Follow-up not reported Participants were recruited previous to 2001 Val-HeFT People with EF 40% and NYHA class II to IV heart failure Age (years): 63 11 Male %: 80 Family origin not reported Setting: Multicentre Country: 16 countries Follow-up not reported Participants were recruited previous to 2001 IN-CHF People with heart failure of any etiology, age, EF or comorbidity Age (years): 64 12 Male %: 76 Family origin not reported Setting: Multicentre Country: Italy Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Follow-up not reported Participant recruitment period not reported May Seattle Heart Failure Model People with HF (defined as a decrease in left ventricular function characterized by an EF 40% or a physician- reported clinical HF diagnosis (i.e., American College of Cardiology/American Heart Association stage B/C) undergoing coronary angiography. Age (years): 67.0 (range 19-96) Male %: 61.4 Family origin not reported Setting: LDS Hospital (Salt Lake City, Utah) Country: USA Average follow-up (years): 4.4 Participants were recruited Mortality at 1 year AUC rate at 1 year The study reported the composite end point of death, transplantati on, and left ventricular assist device implantation. Over 90% of the overall events were mortality. Retrospective cohort Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. 